• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

古吉拉特邦一个部落地区的镰状细胞病患儿的新生儿筛查和临床特征。

Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.

机构信息

SEWA Rural, Jhagadia, Gujarat. Correspondence to: Dr Kapilkumar Dave, Research Associate, SEWA Rural, Jhagadia, Gujarat.

SEWA Rural, Jhagadia, Gujarat.

出版信息

Indian Pediatr. 2022 Mar 15;59(3):230-233. Epub 2022 Jan 9.

PMID:35014619
Abstract

OBJECTIVE

To present the result of newborn sickle cell disease (SCD) screening and clinical profile of SCD newborns in a tribal area of Gujarat.

METHODS

We screened all newborns of sickle cell trait (SCT) and SCD mothers for SCD using high-performance liquid chromatography (HPLC) within two days of birth at a secondary care hospital in a tribal area in Gujarat from 2014 to 2019. Newborns with SCD were registered under an information technology based platform for hospital-based comprehensive care. Neonates were followed prospectively every 3 months. If they missed the clinic visit, a medical counsellor visited them at home to collect the required information.

RESULTS

Out of 2492 newborns screened, 87 (3.5%) were diagnosed with SCD. Among the 67 newborns screened for alpha-thalassemia deletion, 64 (95.4%) of babies had alpha-thalassemia deletion. We recorded total 554 clinic visits over the period of 221.5 person-years. The rates of acute febrile illness, painful crisis, hospitalization and severe anemia were 42.9, 14.9, 14.9 and 4.5 per 100 person-year, respectively. Two deaths were recorded, and 5 babies (5.7%) had severe SCD.

CONCLUSION

We found a high prevalence of alpha thalassemia deletion among newborn SCD cohort in tribal area of Gujarat, and 70% babies had atleast one clinical complication on follow-up.

摘要

目的

展示古吉拉特邦一个部落地区新生儿镰状细胞病(SCD)筛查的结果和 SCD 新生儿的临床特征。

方法

我们在 2014 年至 2019 年期间,在古吉拉特邦一个部落地区的二级保健医院,使用高效液相色谱法(HPLC)在新生儿出生后两天内对所有镰状细胞特征(SCT)和 SCD 母亲的新生儿进行 SCD 筛查。患有 SCD 的新生儿在基于信息技术的医院综合护理平台上进行登记。对新生儿进行前瞻性随访,每 3 个月一次。如果他们错过诊所就诊,医疗顾问会上门家访收集所需信息。

结果

在筛查的 2492 名新生儿中,有 87 名(3.5%)被诊断为 SCD。在对 67 名筛查α-地中海贫血缺失的新生儿中,有 64 名(95.4%)婴儿有α-地中海贫血缺失。在此期间,共进行了 554 次门诊就诊,随访期为 221.5 人年。急性发热性疾病、疼痛危象、住院和严重贫血的发生率分别为每 100 人年 42.9、14.9、14.9 和 4.5。记录了 2 例死亡,5 例婴儿(5.7%)患有严重 SCD。

结论

我们发现古吉拉特邦部落地区新生儿 SCD 队列中α 地中海贫血缺失的发生率很高,70%的婴儿在随访中有至少一种临床并发症。

相似文献

1
Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.古吉拉特邦一个部落地区的镰状细胞病患儿的新生儿筛查和临床特征。
Indian Pediatr. 2022 Mar 15;59(3):230-233. Epub 2022 Jan 9.
2
Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.印度古吉拉特邦南部部落人群镰状细胞病新生儿筛查及随访项目的可行性
J Med Screen. 2015 Mar;22(1):1-7. doi: 10.1177/0969141314557372. Epub 2014 Oct 23.
3
Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India.镰状细胞病与妊娠结局:印度古吉拉特邦一个部落地区社区医院的研究
J Health Popul Nutr. 2017 Jan 21;36(1):3. doi: 10.1186/s41043-017-0079-z.
4
Extremely high birth prevalence of sickle cell disease in rural Tanzania.坦桑尼亚农村极高的镰状细胞病出生率。
Pediatr Blood Cancer. 2020 Nov;67(11):e28620. doi: 10.1002/pbc.28620. Epub 2020 Aug 16.
5
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.德国西南部镰状细胞病的显著流行:一项出生队列研究结果表明新生儿筛查的必要性。
Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12.
6
Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.利用即时检测在低收入环境中进行新生儿镰状细胞病筛查。
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2018-4105. Epub 2019 Sep 17.
7
Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.印度中部镰状细胞病患儿的新生儿筛查及临床结局
PLoS One. 2016 Jan 19;11(1):e0147081. doi: 10.1371/journal.pone.0147081. eCollection 2016.
8
Newborn Screening for Sickle Cell Disease Among Tribal Populations in the States of Gujarat and Madhya Pradesh in India: Evaluation and Outcome Over 6 Years.印度古吉拉特邦和中央邦部落人群镰状细胞病的新生儿筛查:6年评估及结果
Front Med (Lausanne). 2022 Feb 15;8:731884. doi: 10.3389/fmed.2021.731884. eCollection 2021.
9
Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.安达卢西亚西部镰状细胞病的新生儿筛查:实施3年后的结果与经验教训
Am J Perinatol. 2024 May;41(S 01):e893-e900. doi: 10.1055/s-0042-1759646. Epub 2022 Dec 29.
10
Sickle cell disease in tribal populations in India.印度部落人群中的镰状细胞病。
Indian J Med Res. 2015 May;141(5):509-15. doi: 10.4103/0971-5916.159492.

引用本文的文献

1
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.
2
A social profile of deaths related to sickle cell disease in India: a case for an ethical policy response.印度与镰状细胞病相关的死亡的社会特征:需要采取合乎伦理的政策回应。
Front Public Health. 2023 Dec 21;11:1265313. doi: 10.3389/fpubh.2023.1265313. eCollection 2023.